Cancer biomarkers: a systems approach (Q36561609)

14 August 2017

1 reference

title

Cancer biomarkers: a systems approach (English)

1 reference

14 August 2017

0 references

Lee Hartwell

1

1 reference

14 August 2017

David Mankoff

2

1 reference

14 August 2017

Amanda Paulovich

3

1 reference

14 August 2017

Scott Ramsey

4

1 reference

14 August 2017

Elizabeth Swisher

5

1 reference

14 August 2017

1 August 2006

1 reference

14 August 2017

1 reference

14 August 2017

24

1 reference

14 August 2017

905-908

1 reference

14 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/nbt0806-905

14 August 2017

0 references

cites work

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

The case for early detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Ten-year risk of false positive screening mammograms and clinical breast examinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Human leukocyte antigen class II and cervical cancer risk: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Cancer screening. Degrees of proof and practical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

The progress and promise of molecular imaging probes in oncologic drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Metabolic flare: indicator of hormone responsiveness in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

PET imaging of cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Mathematical modeling of cancer: the future of prognosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Endoscopic colorectal cancer screening: a cost-saving analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

inferred from DOI database lookup

7 January 2021

based on heuristic

Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort

1 reference

https://api.crossref.org/works/10.1038%2FNBT0806-905

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NBT0806-905

1 reference

14 August 2017

1 reference